HPV vaccination and allocative efficiency: regional analysis of the costs and benefits with the bivalent AS04-adjuvanted vaccine, from the perspective of public health, for the prevention of cervical cancer and its pre-cancerous lesions. (2012). Farmeconomia. Health Economics and Therapeutic Pathways, 13(2S), 3-15. https://doi.org/10.7175/fe.v13i2S.449